Morningstar Ups Pro Medicus Valuation After Major Contract Win

2 min read | November 28, 2024 07:32 PM EST | By Team Kalkine Media

Highlights

  • Valuation Boost: Morningstar raises Pro Medicus' fair value estimate by 8% to AU$43 per share.
  • Revenue Growth: FY26 revenue forecast increased to AU$275 million, reflecting a key Trinity Health contract.
  • Stock Surge: Pro Medicus shares have more than doubled in value year-to-date.

Pro Medicus Ltd (ASX:PME), a leader in healthcare informatics, has received a significant valuation uplift following a major contract win with Trinity Health. Morningstar analysts have increased the company’s fair value estimate by 8% to AU$43 per share, citing a substantial boost in contracted revenue.

Contract Revenue Spurs Growth Projections

Morningstar attributes the upgraded valuation to an increase in Pro Medicus’ annualized contracted revenue, which is forecast to reach AU$62 million (USD $40.29 million) by FY26, up from a prior estimate of AU$37 million. This growth is primarily driven by the full-year earnings impact of the Trinity Health contract, a deal that highlights Pro Medicus’ competitive strength in the healthcare IT space.

The brokerage now expects Pro Medicus’ total FY26 revenue to hit AU$275 million, a 16.5% increase from its earlier projection of AU$236 million. “We assume a full-year earnings contribution in fiscal 2026, making up 15% of our total revised fiscal 2026 revenue forecast,” Morningstar noted.

Stock Performance Reflects Optimism

Pro Medicus’ shares have been on a stellar trajectory in 2024, more than doubling in value year-to-date. This robust performance underscores investor confidence in the company’s ability to secure high-value contracts and deliver sustainable growth.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.